S100A12

Across TCGA pan-cancer cohorts, S100A12 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated S100A12 data layer compared with 23 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher S100A12 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated S100A12 expression acts as an unfavorable survival marker.

HNSC, SCLC, and LUAD are the cancer types where S100A12 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.057	0.768	<.001	48	view →
SCLC	DFS	Median	II,III,IV	0.137	0.602	.008	18	view →
LUAD	OS	Median	All	0.079	0.788	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

S100A12–HNSC (OS)

Open the HNSC breakdown →